Trevor Allred
Stock Analyst at Oppenheimer
(2.83)
# 1,862
Out of 5,012 analysts
4
Total ratings
71.43%
Success rate
20.23%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Trevor Allred
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MBX MBX Biosciences | Maintains: Outperform | $38 → $80 | $15.80 | +406.33% | 2 | Sep 23, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Outperform | $85 | $70.72 | +20.19% | 1 | Sep 9, 2025 | |
| INVA Innoviva | Initiates: Outperform | $35 | $17.20 | +103.49% | 1 | Aug 11, 2025 |
MBX Biosciences
Sep 23, 2025
Maintains: Outperform
Price Target: $38 → $80
Current: $15.80
Upside: +406.33%
Palvella Therapeutics
Sep 9, 2025
Initiates: Outperform
Price Target: $85
Current: $70.72
Upside: +20.19%
Innoviva
Aug 11, 2025
Initiates: Outperform
Price Target: $35
Current: $17.20
Upside: +103.49%